# The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid

> **NCT02056730** · PHASE4 · COMPLETED · sponsor: **Chulalongkorn University** · enrollment: 60 (actual)

## Conditions studied

- Hyperparathyroidism, Secondary

## Interventions

- **DRUG:** calcium sensing receptor agonist

## Key facts

- **NCT ID:** NCT02056730
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02056730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02056730, "The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02056730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*